Xarelto Lawsuit Plaintiff Claims Drug Manufacturers Responsible For Husband’s Death

May 24, 2016 – – TheProductLawyers.com reports the U.S. Food and Drug Administration (FDA) approval of Xarelto in 2011, which at the time was launched as a new-generation blood thinner drug. Xarelto is unlike its predecessor blood thinners because patients do not require constant monitoring or special diets when using it. These benefits that were not available to patients before and may have contributed to the initial dismissal of the risks associated with the drug. Today, however, these risks are becoming well known because of the thousands of lawsuits filed against the makers of the drug, Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer Healthcare. Plaintiffs in these many lawsuits are claiming that Xarelto is one of the most dangerous blood-thinning drugs on the market due to the risk of uncontrollable bleeding it presents to its users.

Xarelto is now the focus of concern in an excess of 2,800 federally-filed lawsuits from across the United States along with 550 or more additional cases in a mass tort program created by an action of the Court of Common Pleas in Philadelphia, Pennsylvania.

One lawsuit in particular filed by a south Florida resident on behalf of her deceased husband, alleges the manufacturers of the drug failed to sufficiently warn consumers of the serious bleeding risks associated with Xarelto. The plaintiff is claiming that her husband’s use of Xarelto to lessen the threat of having a stroke due to his atrial fibrillation caused his untimely death. He suffered an instance of uncontrollable internal bleeding that doctors could not stop while he was using the drug. This case was eventually transferred to the Eastern District of Louisiana with the U.S. Judicial Panel’s consolidation order which is now being overseen by the Honorable Judge Eldon Fallon.

An action by the U.S. Food and Drug Administration (FDA) has given plaintiffs even more ammunition in their legal battle against the manufacturers of Xarelto. The agency has issued two black box warnings which are the harshest warnings possible prior to a product being fully removed from the market.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010193